Carrie Nichol - Endo International President
President
Ms. Carrie Nichol is appointed as Chief Accounting Officer, Vice President, Controller of the company effective April 2, 2018. She joined the Company in March 2015 as Director of Consolidations and Financial System and currently serves as Assistant Controller. Prior to joining the Company, Ms. Nichol was SVP Controller of Haas Group International where she led the global accounting and finance teams from June 2011 until March 2015. Ms. Nichol also played a critical role in Haas Group Internationals sale to Wesco Aircraft Holdings, Inc. in 2014. Prior to her employment with Haas Group International, Ms. Nichol was with IKON Office Solutions for a total of five years from June 2008 until June 2011 and from June 2003 until July 2005, having served most recently as the Director of Financial Reporting and Corporationrationrate Accounting where she was responsible for all public filings and technical and corporate accounting. From December 2005 until June 2008, Ms. Nichol was with Advanced Metallurgical Group NV serving as Assistant Controller where she led the integration of several business units in anticipation of the companys initial public offering since 2018.
| Age | 37 |
| Tenure | 6 years |
| Professional Marks | MBA |
| Phone | 353 1 268 2000 |
| Web | https://www.endo.com |
Endo International Management Efficiency
The company has return on total asset (ROA) of 5.11 % which means that it generated a profit of $5.11 on every $100 spent on assets. This is normal as compared to the sector avarege. Endo International's management efficiency ratios could be used to measure how well Endo International manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 8.13 B in liabilities with Debt to Equity (D/E) ratio of 1.98, which is about average as compared to similar companies. Endo International PLC has a current ratio of 1.77, which is within standard range for the sector. Debt can assist Endo International until it has trouble settling it off, either with new capital or with free cash flow. So, Endo International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Endo International PLC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Endo to invest in growth at high rates of return. When we think about Endo International's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Odus Wittenburg | Q2 Holdings | 46 | |
| Jamie Beggs | Avient Corp | 47 | |
| Sherri Manning | Q2 Holdings | 48 | |
| David Johnson | American Vanguard | 67 | |
| Kim Rutledge | Q2 Holdings | 51 | |
| Barry Benton | Q2 Holdings | 61 | |
| Adam Blue | Q2 Holdings | 52 | |
| Bob Trogele | American Vanguard | 56 | |
| Vinod Purayath | Avient Corp | 45 | |
| Ulrich Trogele | American Vanguard | 66 | |
| Lorrie Schultz | Q2 Holdings | 48 | |
| Anthony Hendrix | American Vanguard | 53 | |
| Jonathan Price | Q2 Holdings | 40 | |
| Rekha Garapati | Q2 Holdings | 42 | |
| Kirk Coleman | Q2 Holdings | 52 | |
| Andrew Butcher | Luxfer Holdings PLC | 56 | |
Management Performance
| Return On Equity | 0.007 | |||
| Return On Asset | 5.11 |
Endo International PLC Leadership Team
Elected by the shareholders, the Endo International's board of directors comprises two types of representatives: Endo International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Endo. The board's role is to monitor Endo International's management team and ensure that shareholders' interests are well served. Endo International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Endo International's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Carrie Nichol, Chief Accounting Officer, Vice President Controller | ||
| William Spengler, Director | ||
| Arthur Higgins, Independent Director | ||
| Brian Lortie, President U.S. Branded Pharmaceuticals | ||
| Donald DeGolyer, Special Advisor to the CEO | ||
| William Montague, Director | ||
| Michael Hyatt, Director | ||
| Douglas Ingram, Director | ||
| Antonio Pera, President - Par Pharmaceutical | ||
| Domenic Ciarico, Executive Vice President Chief Commercial Officer - Sterile and Generics | ||
| Roger Kimmel, Chairman of the Board | ||
| Susan Hall, Chief Scientific Officer, Global Head of RandD and Quality and Executive VP | ||
| Sharad Mansukani, Director | ||
| Suketu Upadhyay, CFO and Executive VP | ||
| Nancy Hutson, Independent Director | ||
| Todd Sisitsky, Director | ||
| Patrick Barry, Executive Vice President and Chief Commercial Officer | ||
| Shane Cooke, Independent Director | ||
| Craig Paterson, Chief Medical Officer | ||
| Daniel Rudio, Senior Vice President Chief Accounting Officer, Controller | ||
| Camille Farhat, President of American Medical Systems, Inc | ||
| Paul Campanelli, President CEO, Director | ||
| Jill Smith, Director | ||
| Rajiv Silva, CEO and President and Director | ||
| Nina Goworek, Senior Director, Investor Relations | ||
| Blaise Coleman, Senior Vice President of Global Finance Operations and Interim CFO | ||
| Terrance Coughlin, COO, Executive Vice President | ||
| Matthew Maletta, Executive Vice President Chief Legal Officer |
Endo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Endo International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.007 | |||
| Return On Asset | 5.11 | |||
| Profit Margin | (24.82) % | |||
| Operating Margin | 24.70 % | |||
| Current Valuation | 6.84 B | |||
| Shares Outstanding | 233.67 M | |||
| Shares Owned By Insiders | 0.79 % | |||
| Shares Owned By Institutions | 83.64 % | |||
| Number Of Shares Shorted | 41.45 M | |||
| Price To Earning | 0.37 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Endo International in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Endo International's short interest history, or implied volatility extrapolated from Endo International options trading.
Pair Trading with Endo International
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Endo International position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endo International will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Kimco Realty could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kimco Realty when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kimco Realty - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kimco Realty to buy it.
The correlation of Kimco Realty is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kimco Realty moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kimco Realty moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kimco Realty can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Endo International PLC information on this page should be used as a complementary analysis to other Endo International's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Endo Stock
If you are still planning to invest in Endo International PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Endo International's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |